Literature DB >> 12738248

Determinants of HIV-specific CD8 T-cell responses in HIV-infected pediatric patients and enhancement of HIV-gag-specific responses with exogenous IL-15.

Vivek Chitnis1, Rajendra Pahwa, Savita Pahwa.   

Abstract

Cellular immune responses play a central role in controlling HIV-1 infection. HIV-specific IFN-gamma production by CD8 T cells was evaluated in 17 HLA-A2+ HIV-infected pediatric patients (age range 1 month to 16 years) in an ELISPOT assay. Most patients (15/17) exhibited responses to HIV-gag, followed by responses to envelope gp120, gp41, and V3 loop. Only 7 patients responded to all four antigenic peptides. Treatment-related immune reconstitution of CD4 T cells was associated with increase in gag-specific responses, but these declined with prolonged viral suppression. Exogenous IL-15 resulted in augmentation of HIV-gag-specific response in 71% of patients, while IL-2 and IL-7 had variable effects, augmenting responses in 25% patients. Thus, HIV-specific CD8 T-cell responses are dependent on both CD4 T-cell help and antigenic stimulation. The cytokine IL-15 may be a useful modality as adjunctive therapy to augment HIV-specific memory CD8 T cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12738248     DOI: 10.1016/s1521-6616(02)00051-7

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  9 in total

1.  Regulation of lck degradation and refractory state in CD8+ cytotoxic T lymphocytes.

Authors:  Michael Uhlin; Maria G Masucci; Victor Levitsky
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-15       Impact factor: 11.205

2.  Combined IL-15/IL-15Ralpha immunotherapy maximizes IL-15 activity in vivo.

Authors:  Thomas A Stoklasek; Kimberly S Schluns; Leo Lefrançois
Journal:  J Immunol       Date:  2006-11-01       Impact factor: 5.422

Review 3.  Studies of HIV-associated immune responses in lymphoid compartments.

Authors:  Susanna Grundström; Jan Andersson
Journal:  Curr HIV/AIDS Rep       Date:  2006-02       Impact factor: 5.071

4.  Late-emerging strains of HIV induce T-cell homeostasis failure by promoting bystander cell death and immune exhaustion in naïve CD4 and all CD8 T-cells.

Authors:  Catherine N Kibirige; Frederick A Menendez; Hao Zhang; Tricia L Nilles; Susan Langan; Joseph B Margolick
Journal:  Med Hypotheses       Date:  2014-04-13       Impact factor: 1.538

5.  IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-specific CD8+ T cell responses.

Authors:  Yvonne M Mueller; Duc H Do; Susan R Altork; Carol M Artlett; Edward J Gracely; Christos D Katsetos; Agustin Legido; Francois Villinger; John D Altman; Charles R Brown; Mark G Lewis; Peter D Katsikis
Journal:  J Immunol       Date:  2008-01-01       Impact factor: 5.422

6.  Role of common gamma chain utilizing cytokines for immune reconstitution in HIV infection.

Authors:  Savita Pahwa
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

7.  IL-15 mediates immune inflammatory hypernociception by triggering a sequential release of IFN-gamma, endothelin, and prostaglandin.

Authors:  Waldiceu A Verri; Thiago M Cunha; Carlos A Parada; Xiao-qing Wei; Sérgio Henrique Ferreira; Foo Y Liew; Fernando Q Cunha
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-09       Impact factor: 11.205

8.  The role of cytokines which signal through the common gamma chain cytokine receptor in the reversal of HIV specific CD4(+) and CD8(+) T cell anergy.

Authors:  Xiao Xiao Jenny Gu; Feng Yun Yue; Colin M Kovacs; Mario A Ostrowski
Journal:  PLoS One       Date:  2007-03-21       Impact factor: 3.240

9.  Gag-Specific CD4 and CD8 T-Cell Proliferation in Adolescents and Young Adults with Perinatally Acquired HIV-1 Infection Is Associated with Ethnicity - The ANRS-EP38-IMMIP Study.

Authors:  Jérôme Le Chenadec; Daniel Scott-Algara; Stéphane Blanche; Céline Didier; Thomas Montange; Jean-Paul Viard; Catherine Dollfus; Véronique Avettand-Fenoel; Christine Rouzioux; Josiane Warszawski; Florence Buseyne
Journal:  PLoS One       Date:  2015-12-09       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.